OR WAIT 15 SECS
CROMSOURCE has announced the expansion of its Strategic Site Support Service that can be provided to sites participating in clinical research studies managed by CROMSOURCE on behalf of companies in the pharmaceutical, biotechnology, and medical device industries, or to clients and sites directly.
“As we see greater commitment within our industry to conduct patient centric research in which clinic visits can be done outside of regular working hours or remotely via telemedicine, we are seeing a need to flexibly support sites with strategic services provided to our clients or with the provision of staff directly at sites able to support this new way of working. Considering the effects of the global pandemic, provision of additional resources can also be the difference between sites being able to continue to deliver clinical research projects or having to suspend activities ” said Kerry Dyson, Chief Operating Officer at CROMSOURCE.
For more information, click here.